Director of Cardiac Catheterization at the University of Ottawa Heart Institute joins Three Rivers
TORONTO, ON., March 29, 2016 - Interventional Cardiologist and Director of Cardiac Catheterization at the University of Ottawa Heart Institute, Dr. Christopher Glover has joined Three Rivers’ management team as Chief Medical Officer.
“I am pleased to join a dynamic team that develops innovative medical devices providing new solutions to interventional cardiologists,” says Dr. Glover.
Dr. Glover also leads the company’s scientific advisory board where he brings 15+ years of expertise in valve diseases and transcatheter valve replacements.
“His expertise in heart valve diseases and transcatheter valve replacement is an essential asset to our company as our goal is to develop the most valuable solutions for interventional cardiology,” says Eric Caron, CEO of Three Rivers Cardiovascular Systems.
Dr. Glover is part of several committees including: Examination Board for Cardiology and the Specialty Committee in Cardiology, Royal College of Physicians and Surgeons of Canada (FRCPC) .
About Three Rivers:
The company was founded in 2013 to develop and commercialize multi-sensor medical devices for interventional cardiologists. Three Rivers’ innovative medical devices provide real-time critical data for heart diagnosis and therapy to improve patient outcomes while reducing healthcare costs with heart diseases.